- $17.16m
- $12.15m
- $22.03m
Brief: Lifeward Announces Pricing Of $2.6 Million Public Offering
CEO Larry Jasinski To Resign From Board Effective June 30, 2025 - SEC Filing
On June 2, Michael Lawless Resigned As CFO Of Lifeward - SEC Filing
Brief: Lifeward Ltd Files For Mixed Shelf Of Up To $100 Million
Brief: FDA Issues Clearance For Rewalk 7 Exoskeleton
Lifeward soars on FDA nod for exoskeleton device
Brief: Lifeward Streamlines US Operations In Next Phase Of Growth And Operational Efficiencies
Brief: Medicare Revises 2024 Fee Schedule To Include Payment Rate For ReWalk Personal Exoskeleton
Brief: ReWalk Robotics Received Written Notice From Nasdaq On April 3, Stating Co Has Regained Compliance With Minimum Bid Price Requirement
Brief: Rewalk Robotics Rebrands As Lifeward
Brief: ReWalk Robotics Expands Direct Sales Coverage To Canada
Brief: ReWalk Robotics Q3 Adjusted Net Income USD -4.513 Million
Rewalk Robotics Ltd expected to post a loss of 11 cents a share - Earnings Preview
Brief: Rewalk Robotics Notified By Nasdaq That Based Upon Non-Compliance With Minimum Bid Price Rule, Co's Securities Subject To Delisting
Brief: ReWalk Robotics Announces Additional Change To Board Of Directors
Rewalk Robotics Ltd reports results for the quarter ended in June - Earnings Summary
Brief: ReWalk Robotics Ltd. Q2 basic EPS USD -0.08
Rewalk Robotics Ltd expected to post a loss of 7 cents a share - Earnings Preview
Brief: Rewalk Robotics To Acquire Alterg Acquisition Builds Commercial Scale And Accelerates Path To Profitability